We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Geralyn Spollett

Geralyn R Spollett MSN, C-ANP, CDE

Geralyn R. Spollett holds a master of science in nursing with distinction from Boston College, Chestnut Hill, Massachusetts. She has served on the boards of several professional organizations, most notably as Chair of the National Certification Board for Diabetes Educators (NCBDE) and the Executive Board of the American Diabetes Association 2009-2012, President for Health Care and Education in 2012.

She has held a variety of leadership positions at the regional ADA and as a chairperson at the American Nurses Association Credentialing Center. For 10 years she was an Associate Professor at Yale University School of Nursing in the Adult and Family Nurse Practitioner Program and the Diabetes Concentration specialty. She remains involved in the direct care of persons with diabetes specializing in the use of various insulin and sensor technologies. In 2006, she was honored to be the Outstanding Diabetes Educator by the American Diabetes Association.

Ms. Spollett has lectured widely nationally and internationally on both type 1 and type 2 diabetes from a nurse practitioner perspective. She has served as Associate Editor for the journals Diabetes Spectrum and Practical Diabetology as well as the ADA book, The  Complete Nurses Guide for Diabetes, now in its 3rd edition.

Disclosures

Disclosures: Speakers Bureau - Eli Lilly Co.

Advisory Board - Sanofi